Business Description
Biofil Chemicals & Pharmaceuticals Ltd
ISIN : INE829A01014
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.41 | |||||
Interest Coverage | 26.94 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.87 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.2 | |||||
3-Year EBITDA Growth Rate | -19.2 | |||||
3-Year EPS without NRI Growth Rate | -26.8 | |||||
3-Year Book Growth Rate | 5.2 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.01 | |||||
9-Day RSI | 38.93 | |||||
14-Day RSI | 43.92 | |||||
6-1 Month Momentum % | 40.08 | |||||
12-1 Month Momentum % | 59.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 1.17 | |||||
Days Inventory | 24.09 | |||||
Days Sales Outstanding | 222.18 | |||||
Days Payable | 170.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.06 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 5.59 | |||||
Operating Margin % | 2.15 | |||||
Net Margin % | 1.74 | |||||
FCF Margin % | -0.32 | |||||
ROE % | 3.86 | |||||
ROA % | 1.88 | |||||
ROIC % | 3.27 | |||||
ROC (Joel Greenblatt) % | 5.19 | |||||
ROCE % | 5.32 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 157.8 | |||||
PE Ratio without NRI | 157.8 | |||||
Shiller PE Ratio | 89.85 | |||||
PEG Ratio | 45.09 | |||||
PS Ratio | 2.7 | |||||
PB Ratio | 6.07 | |||||
Price-to-Tangible-Book | 5.88 | |||||
EV-to-EBIT | 110.56 | |||||
EV-to-EBITDA | 75.93 | |||||
EV-to-Revenue | 2.72 | |||||
EV-to-FCF | -881.12 | |||||
Price-to-Projected-FCF | 4.21 | |||||
Price-to-DCF (Earnings Based) | 16.45 | |||||
Price-to-Median-PS-Value | 1.63 | |||||
Price-to-Graham-Number | 6.31 | |||||
Price-to-Net-Current-Asset-Value | 11.69 | |||||
Earnings Yield (Greenblatt) % | 0.91 | |||||
FCF Yield % | -0.11 | |||||
Forward Rate of Return (Yacktman) % | 4.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biofil Chemicals & Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 384.483 | ||
EPS (TTM) (₹) | 0.418 | ||
Beta | 0.49 | ||
Volatility % | 32.17 | ||
14-Day RSI | 43.92 | ||
14-Day ATR (₹) | 2.871386 | ||
20-Day SMA (₹) | 67.8165 | ||
12-1 Month Momentum % | 59.02 | ||
52-Week Range (₹) | 41.05 - 78.8 | ||
Shares Outstanding (Mil) | 16.27 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biofil Chemicals & Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biofil Chemicals & Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Biofil Chemicals & Pharmaceuticals Ltd Frequently Asked Questions
What is Biofil Chemicals & Pharmaceuticals Ltd(BOM:524396)'s stock price today?
When is next earnings date of Biofil Chemicals & Pharmaceuticals Ltd(BOM:524396)?
Does Biofil Chemicals & Pharmaceuticals Ltd(BOM:524396) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |